SYNBIOTIC SE Strengthens Its Access To Global Capital
SYNBIOTIC SE is Germany’s largest publicly listed cannabis company (ISIN DE000A3E5A59 | WKN A3E5A5) and an international leader in the emerging legal cannabis and hemp industries.
The company has continued to strengthen its international access to capital through partnerships and cooperation with fundraising specialists and renowned multipliers in North America and Europe, including The Talman Group. Working closely with Hyde Advisory, Bob Hoban, GCNC, and Golden Eagle Partners, in addition to The Talman Group, SYNBIOTIC is building its network.
Earlier this year, SYNBIOTIC collaborated with The Talman Group to achieve a successful funding round for cannabis company GOC Nexus. GOC Nexus received funding from the leading German financial institution Volksbank Donau-Mindel, along with a concurrent investment from SYNBIOTIC SE. The successful funding effort was coordinated by The Talman Group.
By developing international capital sources, SYNBIOTIC can scale faster and more effectively than its competitors. It creates a decisive advantage for both existing and potential investors.
“The cannabis and hemp industry is ready for the next stage of evolution. We want to play a key role in shaping and leading this development. I am firmly convinced that we can achieve this goal with our new partners,” explains Daniel Kruse, Managing Director of SYNBIOTIC.
Hyde Advisory & Investments Inc. is a strategic partner for investor relations and capital acquisition. Hyde Advisory, based in Toronto, is considered a leading consulting firm in the global cannabis sector with a particularly strong network. Led by industry expert David Hyde, the team offers competent support in finding investors, raising capital, transaction processing, due diligence, and corporate risk management.
Bob Hoban, a U.S. lawyer and internationally recognized expert in the cannabis and industrial hemp industry, accompanies SYNBIOTIC in its next major expansion steps. Hoban’s industry knowledge and legal expertise offer valuable support in the development of cross-border strategies, market access, and compliance with legal regulations.
The Global Cannabis Network Collective (GCNC), based in the U.S., was founded by Chris Day and Jillian Reddish. It is an exclusive international network that connects leaders from across the cannabis industry. With his extensive expertise in global collaboration, market trends, and strategic partnerships, Chris Day uses his decades of experience in brand building and business development. GCNC promotes high-profile business deals as well as the exchange of knowledge and contacts between managers in emerging cannabis markets.
The Talman Group is the largest and most influential private network of cannabis investors, entrepreneurs, and executives in Europe. The network was founded to bring together high-level decision-makers inside and outside the cannabis industry and offers an exclusive platform for strategic networking, contracting, and collaboration. Through collaboration, SYNBIOTIC gains access to experienced investors, industry leaders, and innovators, many of whom are actively seeking opportunities for growth-oriented companies in the cannabis and hemp sector. Further joint advertising campaigns and appearances at important industry events are planned to increase the international presence of SYNBIOTIC to expand.
Golden Eagle Partners (GEP), a US company with over nine years of international experience in cannabis transactions, hosts the Global Interactive Webinar (GIW) series – a high-profile platform that brings together global thought leaders from the cannabis and hemp industry GIW brings together recognized experts from the fields finance, science, law, business and politics to gain insights and shape the future of the industry. To bring SYNBIOTIC to a broad international audience, Daniel Kruse will be taking part in the next Spotlight Session with David Traylor, Senior Managing Director of GEP.
